Helen Branswell
Senior Writer, Infectious Diseases and Global Health at STAT
I cover infectious diseases @statnews. 2020 Polk winner. Nieman '11. She/her. #H5N1 #birdflu #Covid #polio #flu, #RSV. Me on Signal: HBranswell.01
Articles
-
4 days ago |
statnews.com | Helen Branswell
For decades, when health care providers in the United States made decisions about who among their patients should be vaccinated against which diseases and when, they knew where to look: the Centers for Disease Control and Prevention, which itself had been advised by a panel of independent experts, the Advisory Committee on Immunization Practices. Those days, at least for now, may be coming to an end.
-
1 week ago |
statnews.com | Helen Branswell
In their first all-staff meeting since the start of the Trump administration, the interim leadership of the Centers for Disease Control and Prevention attempted to sidestep controversy and rally troops at the storied but demoralized agency on Tuesday. Staff were told CDC director nominee Susan Monarez has begun meeting with senators in advance of a still-unscheduled Senate confirmation hearing.
-
1 week ago |
statnews.com | Helen Branswell
The staff of two world-class laboratories at the Centers for Disease Control and Prevention that were slated to be closed in a round of cuts announced in April have been informed that their terminations have been canceled. The CDC’s sexually transmitted disease laboratory and its viral hepatitis laboratory were targets of layoffs initiated by the U.S. Doge Service that was led by Elon Musk.
-
2 weeks ago |
bostonglobe.com | Helen Branswell
This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here. The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include adults aged 18 to 59 who are at high risk of severe illness if they contract respiratory syncytial virus. Previously the vaccine, sold under the name mResvia, was only licensed for use in adults aged 60 and older.
-
2 weeks ago |
statnews.com | Helen Branswell
The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include adults aged 18 to 59 who are at high risk of severe illness if they contract respiratory syncytial virus. Previously the vaccine, sold under the name mResvia, was only licensed for use in adults aged 60 and older.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 221K
- Tweets
- 50K
- DMs Open
- No
The confirmed* #measles count in the US so far in 2025 (*undoubtedly an underestimate) stands at 1197 as of 6/12, per #CDC. Another 78 cases would surpass the 2019 count, which is currently the highest yearly total since measles elimination in the US in 2000 — & we're not yet 6 https://t.co/Y3fzCLd4Hg
Looks like a summer wave of #Covid may be starting in Europe, per @ECDC_EU. https://t.co/hUNeKZEMBu
#CDC learned last week of another 5 kids who died from #flu this winter, bringing the total (so far) to a staggering 246 pediatric flu deaths in 2024-25. These deaths occurred between Feb & the end of April. Among the kids with known vaccination status, 90% were unvaxed. https://t.co/qPcy1npbsT